10x Genomics Inc.

NASDAQ: TXG · Real-Time Price · USD
13.34
0.10 (0.76%)
At close: Aug 15, 2025, 3:05 PM

10x Genomics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-84.6M -157.04M -182.63M -182.55M -239.78M -264.3M -255.1M -223.36M -172.29M -174.33M -166M -167.23M -142.49M -89.08M -58.22M -455.35M -504.02M -533.14M
Depreciation & Amortization
40.78M 42.03M 43.71M 44.85M 45.52M 46.5M 43.62M 40.38M 37.08M 33.65M 33.01M 31.86M 31.02M 29.76M 28.25M 26.35M 23.95M 21.23M
Stock-Based Compensation
124.76M 135.7M 140.75M 147.13M 153.77M 160.98M 166.95M 169.01M 162.28M 152.9M 136.85M 122.78M 115.21M 105.83M 95.96M 83.33M 71.16M 58.08M
Other Working Capital
-1.41M -663K -12.57M 4.29M 32.95M 32.65M 26.1M 5.4M -18.24M -15.68M -5.13M -1.34M -29.82M -43.53M -34.36M -56.99M -30.05M -29.72M
Other Non-Cash Items
-196K 221K 3.58M -13.8M 12.63M 13.02M 11.99M 29.66M 3.83M 3.64M 1.96M 1.13M 65.02M 64.78M 64.63M 370.61M 306.06M 306.03M
Deferred Income Tax
n/a n/a n/a 23.85M -2.79M n/a n/a -23.85M 2.79M n/a n/a n/a n/a n/a n/a 29K 29K 29K
Change in Working Capital
-13.79M 35.83M 1.25M 19.7M 22.87M 17.01M 17.34M -19.07M -45.18M -32.78M -39.42M -30.06M -62.39M -84.83M -87.44M -117.77M -83.94M -71.64M
Operating Cash Flow
66.95M 56.74M 6.66M 39.17M -7.78M -26.8M -15.2M -27.23M -11.49M -16.93M -33.61M -41.52M -58.18M -38.09M -21.37M -157.35M -186.77M -219.4M
Capital Expenditures
-10.08M -12.38M -13.39M -14.13M -25.67M -47.15M -49.52M -85.81M -106.94M -108.81M -131.66M -119.55M -103.2M -90.55M -101.28M -95.93M -77.01M -69.18M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a -2.5M -4M -2.5M -1M 1.5M 3M 1.5M -5.45M -5.45M -5.45M -5.45M
Purchase of Investments
-49.36M n/a n/a n/a n/a n/a n/a -1.5M -12.82M -42.04M -284.37M -282.87M -271.55M -242.33M n/a n/a n/a n/a
Sales Maturities Of Investments
50.27M 16.1M 29.64M 46.19M 66.25M 71.32M 183.02M 175.53M 171.96M 179.98M 67.64M 58.58M 41.82M 12.91M n/a n/a n/a n/a
Other Investing Acitivies
-48.88M -48.88M -48.88M n/a n/a 20.89M 145.41M 146.91M 152.35M 129.96M 3.94M 2.44M -3M -1.5M n/a -927K -1.73M -1.73M
Investing Cash Flow
-58.04M -45.16M -32.63M 32.06M 40.58M 24.17M 133.49M 87.22M 49.69M 26.63M -350.89M -345.33M -332.93M -319.97M -106.73M -101.38M -82.46M -74.63M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 5.85M 5.85M 5.85M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
3.52M n/a n/a n/a n/a 7.1M 1.28M 6.28M 8.32M 7.59M 15.82M 19.72M 24.36M 34.2M 35.3M 29.03M 509.32M 501.18M
Financial Cash Flow
8.62M 9.7M 10.91M 12.01M 16.23M 18.72M 13.67M 13.06M 10.72M 9.99M 15.82M 19.72M 24.36M 34.2M 35.3M 34.1M 514.38M 506.24M
Net Cash Flow
17.89M 21.28M -15.22M 83.42M 48.97M 15.99M 131.93M 73.19M 49.06M 19.68M -368.72M -367.51M -366.92M -323.85M -92.57M -224.63M 245.02M 212.05M
Free Cash Flow
56.88M 44.36M -6.73M 25.04M -33.45M -73.95M -64.72M -113.04M -118.44M -125.74M -165.27M -161.07M -161.38M -128.64M -122.65M -253.28M -263.77M -288.58M